HOERTER STEVEN L. (President & CEO) sold 29.6% of their position (30.66K shares) of DECIPHERA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $471.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/14/2023ACC: 0000950170-23-070386
DirectorOfficer· President & CEO
Since Mar 2019
+31.84K
Net shares
Net buyer
$471.2K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
62.50K acquired · 30.66K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+62.50K
Price / share
—
Trade value
—
% of position
152.7%
12/12/2023
40.93K→103.43K
Common Stock
Direct
Shares
−30.66K
Price / share
$15.37
Trade value
$471.22K
% of position
29.6%
12/13/2023
103.43K→72.76K
Total
Net shares
+31.84K
Net value
-$471.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2023 | A · Award | +62.50K | — | — | 152.7% | 40.93K | 103.43K |
| Common Stock Direct | 12/13/2023 | S · Sale | −30.66K | $15.37 | $471.22K | 29.6% | 103.43K | 72.76K |
| Total | +31.84K | -$471.22K | ||||||
Derivative Transactions0
No derivative transactions reported